주요서비스 바로가기
본문 바로가기
매체정보 바로가기
로그인 바로가기
기사검색 바로가기
전체서비스 바로가기
상단영역
UPDATE : 2024-04-26 16:52 (Fri)
Home
Log in
Join
전체메뉴
기사검색
검색
본문영역
Pharma
목록
(
총 :
701 )
기사목록 보기 형태
제목형
요약형
포토형
Bioplus-Interphex 2023: Korea launches business council to boost microbiome competitiveness
Marianne Chang
2023.07.13 17:06
Sanofi’s cold agglutinin disease treatment Enjaymo lands in Korea
Kim Yun-mi
2023.07.13 16:00
Cytiva report reveals Korea’s strengths in bio policies but downfall in R&D
Marianne Chang
2023.07.13 14:41
Hanmi’s eye drop faces 2-month sale ban after failing to submit drug reevaluation data
Lee Han-soo
2023.07.13 10:20
'Korea's negative perception of HIV hindering patient diagnosis'
Lee Han-soo
2023.07.12 16:10
Regulator keeps close eye on GLP-1 weight loss drugs' possible link to suicidal thoughts
Lee Han-soo
2023.07.12 14:20
Pfizer's Cibinqo affordable at $77/month with reimbursement for severe atopic dermatitis
Lee Han-soo
2023.07.11 17:03
BeiGene’s Brukinsa expands indication for CLL, SLL in Korea
Marianne Chang
2023.07.11 14:16
Lotte Biologics, Kanaph Therapeutics pursue joint ADC tech platform
Marianne Chang
2023.07.11 10:32
HK inno.N aiming to monopolize GERD market launches K-CAB in Indonesia
Marianne Chang
2023.07.11 09:54
Bankrupt US partner of Hanmi hands over oral drug discovery platform tech to Hong Kong firm
Lee Han-soo
2023.07.10 16:50
‘Leclaza showed consistent global PFS results as 1st-line NSCLC treatment’
Marianne Chang
2023.07.10 14:51
처음
이전
이전
이전
51
52
53
54
55
56
57
58
59
끝
위로
전체메뉴
All
Hospital
Pharma
Bio
All
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
All
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
ASCO 2020 Highlights
Special Series in Celebration of KBR’s 4th Anniversary
KBR Covering RSNA 2021
Special Series in Celebration of KBR’s 5th Anniversary
Special Report on EULAR 2022
[Top K-Pharma Analysis]
BIO 2023
Opinion
All
Reporter’s Notebook
Journalist’s Column
Congratulatory Remarks
Sponsored
전체메뉴닫기